Article · 19 Jun 2026
Research articlePublished 26 Sep 2022
Drug-Induced Xerostomia: The Physical, Mental, and Economic Impact
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Many medications utilized in the United States (US) cause xerostomia (dry mouth); however, the costs and Quality Of Life (QOL) reduction associated with this side effect remains to be determined. Objective: To estimate the annual dental expenditures and quality of life burden attributable to chronic use of medications that cause xerostomia in the US adult population. Methods: This was a cross-sectional retrospective analysis evaluating prescribed medications in 2019 as reported by the Medical Expenditure Panel Survey. Medications were organized in 2 groups: medications with and without documentation of xerostomia. The treatment group included the US non-institutionalized adult population with chronic use of xerostomia causing medications. The control group included the rest of the US non-institutionalized adult population. Dental visits per year, total annual dental expenditures, and annual self-pay (out-of-pocket) dental expenditures were compared between treatment and control populations. Health related physical and mental quality of life scores were also compared. Results: Those in the treatment group exhibited a 33.3% higher expected rate of dental visits per year. Treatment populations also incurred higher dental expenditures $523.830/year vs. $315.78/year (p<0.001), and self- expenditures $266 vs. $131/year (p<0.001). Importantly, the treatment arm has lower physical and mental health, are older and sicker, thus, an adjusted analysis was necessary. Following the adjusted analysis, the difference of 1.3 (p<0.001) for physical and 2.0 (p<0.001) for mental summary scores remained. Conclusion: This study shows that medications that cause xerostomia result in higher dental costs and have a negative impact on physical and mental health.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Leticia A. Shea”
- BylineArticles whose byline prints “Vahram Ghushchyan”
- BylineArticles whose byline prints “Madalyn Kuhlenberg”
